The panel reviewed safety and efficacy data from a phase 2/3 study that included 2268 participants who received a 2-dose regimen of 10mcg administered 21 days apart.
The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.
Agency will not recommend one vaccine over another but may say it is preferable to use same booster as the vaccine.
The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.
With children back in school and COVID-19 cases persisting, parents may be concerned and seek information about the vaccine. What should they know about the COVID-19 vaccine for children?
NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
Routine annual influenza vaccination is recommended for all patients 6 months of age and older who have no medical contraindications.
A single booster dose may be administered to individuals 65 years and older and those at high risk of severe disease or exposure to SARS-CoV-2.
New research indicates two doses of the vaccine boosts immunity from 74% to 94%
President Joe Biden uses the full authority of his presidency to push Federal and health care workers to get vaccinated against COVID-19.
Estimates of vaccine effectiveness high for adults 85 years and older, those with chronic medical conditions, and for Hispanic and Black adults.
A third dose of the Pfizer COVID-19 vaccine gives 4 times greater protection against COVID-19 infection, according to Israeli study.
Comirnaty is indicated for individuals 16 years of age and older, however the vaccine remains available to those aged 12 years and older under the EUA.
Federal health officials are waiting on clinical trial results to determine whether a second shot of the J&J vaccine or a booster using another vaccine is best.
Americans will be able to start getting a booster of the mRNA COVID-19 vaccine starting September 20, 2021.
Daily number rose from 226,209 on July 5 to about 441,198 on Aug. 5
Latest recommendation comes after new data showed no raised risk for miscarriage in mothers-to-be during first 20 weeks
Push will include enlisting pediatricians to make COVID-19 vaccination part of back-to-school sports physicals.
The efficacy data was based on a final analysis of the phase 3 COVE study which evaluated the mRNA-1273 vaccine in more than 30,000 adults aged 18 years and older.
Review of the 2021 Advisory Committee Immunization Practices updates to the pediatric immunization schedule during COVID-19.